ICON Public (ICLR) Stock Forecast & Price Target

$287.56

-2.81 (-0.97%)

(As of 10/8/2024 ET)

ICON Public - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 12 Analyst Ratings

Sell
0

Hold
0

Buy
12

Based on 12 Wall Street analysts who have issued ratings for ICON Public in the last 12 months, the stock has a consensus rating of "Buy." Out of the 12 analysts, 11 have given a buy rating, and 1 has given a strong buy rating for ICLR.

Consensus Price Target

$353.60
22.97% Upside

According to the 12 analysts' twelve-month price targets for ICON Public, the average price target is $353.60. The highest price target for ICLR is $383.00, while the lowest price target for ICLR is $315.00. The average price target represents a forecasted upside of 22.97% from the current price of $287.56.

Get the Latest News and Ratings for ICLR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for ICON Public and its competitors.

ICLR Analyst Ratings Over Time

Type	Current Forecast 10/9/23 to 10/8/24	1 Month Ago 9/9/23 to 9/8/24	3 Months Ago 7/11/23 to 7/10/24	1 Year Ago 10/9/22 to 10/9/23
Strong Buy	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	11 Buy rating(s)	10 Buy rating(s)	10 Buy rating(s)	6 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$353.60	$352.56	$346.20	$269.22
Forecasted Upside	22.97% Upside	16.54% Upside	5.34% Upside	12.86% Upside
Consensus Rating	Buy	Buy	Buy	Buy

[SHOCKING] Crypto Document Leak… (Ad)

The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes.

Download your digital copy now

ICLR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ICLR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

ICON Public Stock vs. The Competition

Type	ICON Public	Medical Companies	S&P 500
Consensus Rating Score	3.08	2.78	2.50
Consensus Rating	Buy	Moderate Buy	Hold
Predicted Upside	22.27% Upside	10,819.51% Upside	7.88% Upside
News Sentiment Rating	Neutral News See Recent ICLR News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/8/2024	Evercore ISI 2 of 5 stars		Lower Target	Outperform ➝ Outperform	$360.00 ➝ $350.00	+21.46%
9/20/2024	Robert W. Baird 2 of 5 stars		Lower Target	Outperform ➝ Outperform	$368.00 ➝ $340.00	+12.99%
9/18/2024	Leerink Partnrs 0 of 5 stars	M. Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
9/18/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$379.00	+29.55%
9/11/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$383.00 ➝ $383.00	+32.07%
7/26/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$355.00 ➝ $350.00	+9.91%
Get the Latest News and Ratings for ICLR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ICON Public and its competitors with MarketBeat's FREE daily newsletter.
6/6/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$370.00	+12.24%
5/31/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform
5/31/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$349.00 ➝ $373.00	+15.09%
4/4/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$346.00	+7.76%
12/20/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$295.00 ➝ $330.00	+18.21%
12/11/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$300.00 ➝ $315.00	+15.61%
7/14/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$280.00 ➝ $300.00	+21.55%
5/1/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$245.00 ➝ $220.00	+14.17%
4/28/2023	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$271.00 ➝ $263.00	+37.91%
11/9/2022	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$265.00 ➝ $260.00	+33.29%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 10:17 PM ET.

Should I Buy ICON Public Stock? ICLR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, October 6, 2024. Please send any questions or comments about these ICON Public pros and cons to contact@marketbeat.com.

ICON Public
Bull Case

Here are some ways that investors could benefit from investing in ICON Public Limited:

ICON Public Limited has a debt-to-equity ratio of 0.36, indicating a strong financial position with lower debt levels compared to equity, which can be attractive to investors seeking stability.
The company's quick ratio and current ratio both stand at 1.31, suggesting that ICON Public Limited has good liquidity to meet its short-term obligations, a positive sign for investors concerned about the company's ability to cover immediate liabilities.
Analysts predict that ICON Public Limited will post $14.55 earnings per share for the current year, indicating strong potential for profitability and growth, which can be appealing to investors looking for high returns.
Recent trading data shows that ICON Public Limited's stock price is currently at $296.30, which may present a buying opportunity for investors looking to enter the market at a potentially lower price point.
With a consensus rating of "Buy" and an average target price of $351.60, analysts and market sentiment are positive about ICON Public Limited's future performance, providing confidence to investors considering the stock.

ICON Public
Bear Case

Investors should be bearish about investing in ICON Public Limited for these reasons:

While the company's financial ratios indicate strength, there may be a risk of overvaluation in the stock price, especially considering the current PE ratio of 36.05 and a PEG ratio of 1.29, which could deter value-oriented investors.

ICLR Forecast - Frequently Asked Questions

: According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for ICON Public is $353.60, with a high forecast of $383.00 and a low forecast of $315.00.
: 12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ICON Public in the last year. There are currently 11 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ICLR shares.
: According to analysts, ICON Public's stock has a predicted upside of 22.97% based on their 12-month stock forecasts.
: Over the previous 90 days, ICON Public's stock had 1 upgrade by analysts.
: ICON Public has been rated by research analysts at Barclays, Evercore ISI, Leerink Partners, Leerink Partnrs, Robert W. Baird, and Truist Financial in the past 90 days.
: Analysts like ICON Public more than other "medical" companies. The consensus rating for ICON Public is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ICLR compares to other companies.